fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

Rheumatoid arthritis drug cuts mortality among COVID-19 ventilated patients

Written by | 19 Feb 2022

Critically ill COVID-19 patients already on mechanical ventilation or extracorporeal membrane oxygenation have achieved a significantly higher rate of survival when randomized to receive baricitinib, a treatment for… read more.

Antibodies improve in quality for months after COVID-19 vaccination

Written by | 18 Feb 2022

For at least six months after COVID-19 vaccination, antibodies produced by immune cells become steadily more formidable and more precisely targeted against the virus that causes COVID-19, according… read more.

Third wave of COVID-19 hit rural America especially hard

Written by | 16 Feb 2022

The third wave of the COVID-19 pandemic in the summer of 2021 spread far faster in rural America, much of which has low rates of vaccination. A new… read more.

Most workers experience multiple, interconnected vulnerabilities to COVID-19

Written by | 15 Feb 2022

COVID-19 has had a devastating impact on people’s physical and mental health and has caused economic hardship. However, this adversity has disproportionately hurt certain populations—including essential workers and… read more.

COVID-19 increases risk of pregnancy complications, study suggests

Written by | 11 Feb 2022

Pregnant women with COVID-19 appear to be at greater risk for common pregnancy complications — in addition to health risks from the virus — than pregnant women without… read more.

Research strongly suggests COVID-19 virus enters the brain

Written by | 8 Feb 2022

More and more evidence is coming out that people with COVID-19 are suffering from cognitive effects, such as brain fog and fatigue. And researchers are discovering why. The… read more.

Current anti-COVID pills work well against omicron, but antibody drugs are less effective, study finds

Written by | 30 Jan 2022

The drugs behind the new pills to treat COVID-19 remain very effective against the omicron variant of the virus in lab tests, according to a new study. However,… read more.

Vaping worsens frequency of COVID symptoms

Written by | 24 Jan 2022

Electronic cigarette users who tested positive for COVID-19 reported a higher frequency of COVID-19 symptoms than similar patients who don’t vape, researchers reported on Jan.13, 2022 in the Journal… read more.

Computer model seeks to explain the spread of misinformation, and suggest counter measures

Written by | 22 Jan 2022

Misinformation may spread like a disease, while previously held beliefs limit influence of new information. Researchers have come up with a computer model that mirrors the way misinformation… read more.

EU backs new COVID-19 treatments

Written by | 13 Jan 2022

The European Medicines Agency (EMA) has authorised several new therapies and vaccines for COVID-19 which offer fresh hope of containing the two-year old pandemic, the EU drug watchdog… read more.

Memory T cells from previous common cold infections protect against infection with SARS-CoV-2

Written by | 11 Jan 2022

A new study, published in Nature Communications confirms what many people have suspected for a long time – namely that previous human coronavirus infection e.g. with the common cold, could… read more.

Are hedgehogs to blame for superbugs?

Written by | 10 Jan 2022

The threat of antimicrobial resistance (AMR), whereby antibiotics not longer work well on bacterial illness, is a slow-burning pandemic with the potential to eclipse even the worst of… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.